Abstract
More than half of the patients with angiographically confirmed premature coronary heart disease (CHD) have a familial lipoprotein disorder1. Familial combined hyperlipidaemia (FCHL) represents the most common genetic dyslipidemia with a prevalence of 1.0–2.0% (refs 2,3). FCHL is estimated to cause 10–20% of premature CHD (ref. 1) and is characterized by elevated levels of cholesterol, triglycerides, or both3,4. Attempts to characterize genes predisposing to FCHL have been hampered by its equivocal phenotype definition, unknown mode of inheritance and genetic heterogeneity. In order to minimize genetic heterogeneity, we chose 31 extended FCHL families from the isolated Finnish population5 that fulfilled strictly defined criteria for the phenotype status. We performed linkage analyses with markers from ten chromosomal regions that contain lipid-metabolism candidate genes. One marker, D1S104, adjacent to the apolipoprotein A-ll (APOA2) gene on chromosome 1, revealed a lod score of Z=3.50 assuming a dominant mode of inheritance. Multipoint analysis combining information from D1S104 and the neighbouring marker D1S1677 resulted in a lod score of 5.93. Physical positioning of known genes in the area (APOA2 and three selectin genes) outside the linked region suggests a novel locus for FCHL on 1q21-q23. A second paper in this issue (Castellani et al.) reports the identification of a mouse combined hyperlipidaemia locus in the syntenic region of the mouse genome6, thus further implicating a gene in this region in the aetiology of FCHL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Genest, J.J. Jr., et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85, 2025–2033 (1992).
Grundy, S.M., Chait, A. & Brunzell, J.D. Familial combined hyperlipidemia workshop. Arteriosclerosis 7, 203–207 (1987).
Goldstein, J.L., Schrott, H.G., Hazzard, W.R., Bierman, E.L. & Motulsky, A.G. Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin. Invest. 52, 1544–1568 (1973).
Nikkilä, E.A. & Aro, A. Family study of serum lipids and lipoproteins in coronary heart disease. Lancet 1, 954–959 (1973).
De la Chapelle, A. Disease gene mapping in isolated human populations: the example of Finland. J. Med. Genet. 30, 857–865 (1993).
Castellani et al. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain. Nature Genet. 18, 372–375 (1998).
Cullen, P., Farren, B., Scott, J. & Farrall, M. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia. Arterioscler. Tromb. 14, 1233–1249 (1994).
Jarvik, G.P. et al. Genetic predictors of FCHL in four large pedigrees. Influence of apoB level major locus predicted genotype and LDL subclass phenotype. Arterioscler. Thromb. 14, 1687–1694 (1994).
Austin, M.A., Brunzell, J.D., Fitch, W.L. & Krauss, R.M. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 9, 335–344 (1989).
Nishina, P.M., Johnson, J.P., Naggert, J.K. & Krauss, R.M. Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc. Natl. Acad. Sci. USA 89, 708–712 (1992).
Wojciechowski, A.P. et al. Familial combined hyperlipidaemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23-q24. Nature 349, 161–164 (1991).
Dallinga-Thie, G.M. et al. Complex genetic contribution of the apo AI-CII-AIV gene cluster to familial combined hyperlipidemia. J. Clin. Invest. 99, 953–961 (1997).
Marcil, M. et al. Lack of association of the apolipoprotein A-I-C-III-A-IV gene Xmnl and Sstl polymorphisms and of the lipoprotein lipase mutations in familial combined hyperlipoproteinemia in French Canadian subjects. J. Lipid Res. 37, 309–319 (1996).
Kwiterovich, P.O. Jr., Genetics and molecular biology of familial combined hyperlipidemia. Curr. Opin. Lipidol. 4, 133–143 (1993).
Reymer, P.W.A. et al. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum. Mol. Genet. 4, 1543–1549 (1995).
Pajukanta, P. et al. No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families. Arterioscler. Thromb. Vase. Biol. 17, 841–850 (1997).
Terwilliger, J.D. A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am. J. Hum. Genet 56, 777–787 (1995).
Terwilliger, J.D., Zöllner, S., Laan, M. & Pääbo, S. Mapping genes through the use of linkage disequilibrium generated by genetic drift. Hum. Hered. (in press).
Weiss, K.M. Genetic Variation and Human Disease: Principles and Evolutionary Approaches. (Cambridge University Press, Cambridge, 1995).
Paigen, B. et al. Ath1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc. Natl. Acad. Sci. USA 87, 3763–3767 (1987).
Voutilainen, E. Serum lipids and lipoproteins in male survivors of acute myocardial infarction and their first-degree relatives: a case-control study. (Kuopio University Publications D: Medical Sciences, Kuopio, Finland, 1992).
Vartiainen, E. et al. Twenty-year trends in coronary risk factors in North Karelia and in other areas of Finland. Int. J. Epidemiol. 23, 495–504 (1994).
Porkka, K.V.K., Viikari, J., Rönnemaa, T., Marniemi, J. & Åkerblom, H.K. Age and gender specific serum lipid percentiles of Finnish children and young adults. The Cardiovascular Risk in Young Finns study. Acta Paediatr. 83, 838–848 (1994).
Cuthbert, J.A., East, C.A. & Bilheimer, D.W. Detection of familial hypercholesterolemia by assaying functional low-density-lipoprotein receptors on lymphocytes. N. Engl. J. Med. 314, 879–883 (1986).
Syvänen, A.-C., Sajantila, A. & Lukka, M. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am. J. Hum. Genet. 52, 46–59 (1993).
Ott, J. Analysis of Human Genetic Linkage. 2nd ed. (Johns Hopkins University Press, Baltimore, 1991).
Lathrop, G.M., Lalouel, J.-M., Julier, C.A. & Ott, J. Strategies for multilocus linkage analysis in humans. Proc. Natl. Acad. Sci. USA 81, 3443–3446 (1984).
Cottingham, R.W. Jr., Idury, R.M. & Schaffer, A.A. Faster sequential genetic linkage computations. Am. J. Hum. Genet 53, 252–263 (1993).
Schaffer, A.A., Gupta, S.K., Shriram, K. & Cottingham, R.W., Avoiding recomputation in linkage analysis. Hum. Hered. 44, 225–237 (1994).
Risch, N. & Giuffra, L. Model misspecification and multipoint linkage analysis. Hum. Hered. 42, 77–92 (1992).
Terwilliger, J.D. & Ott, J. A novel polylocus method for linkage analysis using the lod- score or affected sib-pair method. Genet. Epidemiol. 10, 477–482 (1993).
Terwilliger, J.D. Linkage analysis - model based, in Encyclopedia of Biostatistics. (eds Armitage, P. & Cotton, T.) (John Wiley & Sons), in press.
Durner, M., Greenberg, D.A. & Hodge, S.E. Inter- and intrafamilial heterogeneity: effective sampling strategies and comparison of analysis methods. Am. J. Hum. Genet. 51, 859–870 (1992).
Kuokkanen, S. et al. Putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nature Genet. 13, 477–480 (1996).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pajukanta, P., Nuotio, I., Terwilliger, J. et al. Linkage of familial combined hyperlipidaemia to chromosome 1q21–q23. Nat Genet 18, 369–373 (1998). https://doi.org/10.1038/ng0498-369
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0498-369
This article is cited by
-
Upstream Transcription Factor 1 (USF1) allelic variants regulate lipoprotein metabolism in women and USF1 expression in atherosclerotic plaque
Scientific Reports (2014)
-
OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism
Journal of Molecular Medicine (2009)
-
TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia
Diabetologia (2007)
-
Refined localization of the FAT1 quantitative trait locus on pig chromosome 4 by marker-assisted backcrossing
BMC Genetics (2006)
-
The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia
International Journal of Obesity (2006)